INNT
TOTAL INVALIDATION PROCESSED BY THE IB
08/10/2024
Back to search
Official data from USPTO
ARTICUL ONE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ARTICUL ONE
ST13
US500000079192220Class
5, 10
Filing
79192220
Registration
5173753
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
08/10/2024
Trademark type
Word
Nice classes
5, 10
Filing date
05/04/2016
Registration date
04/04/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/20/2023
Last transaction
10/23/2023
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
11
Owner location
KR
Examiner
TAYLOR, DAVID T
Law office
M30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Medytox Inc.
Representatives
Y.P.LEE, MOCK & PARTNERS
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical and veterinary preparations for treatment of arthritis and osteoarthritis; drugs for medical purposespharmaceutical preparations for arthritis and osteoarthritis; medical preparations made of solutions of hyaluronic acid or modified hyaluronic acid for the treatment of arthritis and osteoarthritis; medical hyaluronic acid or modified hyaluronic acid used for treatment or prevention of arthritis or osteoarthritis in the form of injection to inject into joints; Drugs for medical purposesimproving the function of articular cartilage
Class 10
Medical filler syringes; syringes for injection of medical substances; syringes for medical purposes and for injections; injection device for pharmaceuticals; joint prostheses; injection devices for pharmaceuticalsused to inject hyaluronic acid for treatment or prevention of arthritis or osteoarthritis
Publications
History of USPTO decisions and trademark events.
28 publications found
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
07/25/2024
INPC
INVALIDATION PROCESSED
07/25/2024
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
06/21/2024
C71T
CANCELLED SECTION 71
10/20/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/28/2017
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/07/2017
FIMP
FINAL DISPOSITION PROCESSED
07/07/2017
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/04/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
04/04/2017
GPNX
NOTIFICATION PROCESSED BY IB
01/26/2017
PUBO
PUBLISHED FOR OPPOSITION
01/17/2017
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/11/2017
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
01/11/2017
NPUB
NOTICE OF PUBLICATION
12/28/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/11/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/18/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/18/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/18/2016
RFNP
REFUSAL PROCESSED BY IB
10/16/2016
MAFR
APPLICATION FILING RECEIPT MAILED
09/28/2016
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/27/2016
RFRR
REFUSAL PROCESSED BY MPU
09/27/2016
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/25/2016
CNRT
NON-FINAL ACTION WRITTEN
09/24/2016
DOCK
ASSIGNED TO EXAMINER
09/24/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/24/2016
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/22/2016
Continuous trademark protection
Get notified about every new filing that threatens ARTICUL ONE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.